• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RSK2 成为人类皮肤癌防治的新靶点。

A Rising Cancer Prevention Target of RSK2 in Human Skin Cancer.

机构信息

College of Pharmacy, The Catholic University of Korea , Bucheon-si , Republic of Korea.

出版信息

Front Oncol. 2013 Aug 5;3:201. doi: 10.3389/fonc.2013.00201. eCollection 2013.

DOI:10.3389/fonc.2013.00201
PMID:23936765
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3733026/
Abstract

RSK2 is a p90 ribosomal S6 kinase family (p90(RSK)) member regulating cell proliferation and transformation induced by tumor promoters such as epithelial growth factor (EGF) and 12-O-tetradecanoylphorbol-13-acetate. This family of p90(RSK) has classified as a serine/threonine kinase that respond to many growth factors, peptide hormones, neurotransmitters, and environmental stresses such as ultraviolet (UV) light. Our recent study demonstrates that RSK2 plays a key role in human skin cancer development. Activation of RSK2 by EGF and UV through extracellular-activated protein kinases signaling pathway induces cell cycle progression, cell proliferation, and anchorage-independent cell transformation. Moreover, knockdown of RSK2 by si-RNA or sh-RNA abrogates cell proliferation and cell transformation of non-malignant human skin keratinocyte, and colony growth of malignant melanoma (MM) cells in soft agar. Importantly, activated and total RSK2 protein levels are highly detected in human skin cancer tissues including squamous cell carcinoma, basal-cell carcinoma, and MM. Kaempferol and eriodictyol are natural substances to inhibit kinase activity of the RSK2 N-terminal kinase domain, which is a critical kinase domain to transduce their activation signals to the substrates by phosphorylation. In this review, we discuss the role of RSK2 in skin cancer, particularly in activation of signaling pathways and potent natural substances to target RSK2 as chemopreventive and therapeutic agents.

摘要

RSK2 是 p90 核糖体 S6 激酶家族(p90(RSK))的成员,可调节肿瘤促进剂(如表皮生长因子 (EGF) 和 12-O-十四烷酰佛波醇-13-醋酸酯)诱导的细胞增殖和转化。该 p90(RSK) 家族被归类为丝氨酸/苏氨酸激酶,可响应许多生长因子、肽激素、神经递质和环境应激物,如紫外线 (UV)。我们最近的研究表明,RSK2 在人类皮肤癌的发展中起着关键作用。EGF 和 UV 通过细胞外激活蛋白激酶信号通路激活 RSK2,可诱导细胞周期进程、细胞增殖和非依赖性细胞转化。此外,通过 si-RNA 或 sh-RNA 敲低 RSK2 可阻断非恶性人类皮肤角质形成细胞的增殖和转化,以及软琼脂中恶性黑色素瘤 (MM) 细胞的集落生长。重要的是,在包括鳞状细胞癌、基底细胞癌和 MM 在内的人类皮肤癌组织中高度检测到活化和总 RSK2 蛋白水平。山奈酚和圣草酚是抑制 RSK2 N 端激酶结构域激酶活性的天然物质,该激酶结构域是通过磷酸化将其激活信号转导至底物的关键激酶结构域。在这篇综述中,我们讨论了 RSK2 在皮肤癌中的作用,特别是在信号通路的激活和强效天然物质靶向 RSK2 作为化学预防和治疗剂方面的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6099/3733026/3644fedc227e/fonc-03-00201-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6099/3733026/3451e23e9f21/fonc-03-00201-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6099/3733026/888a2b8832b9/fonc-03-00201-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6099/3733026/4a9cc1dd45ba/fonc-03-00201-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6099/3733026/3644fedc227e/fonc-03-00201-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6099/3733026/3451e23e9f21/fonc-03-00201-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6099/3733026/888a2b8832b9/fonc-03-00201-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6099/3733026/4a9cc1dd45ba/fonc-03-00201-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6099/3733026/3644fedc227e/fonc-03-00201-g004.jpg

相似文献

1
A Rising Cancer Prevention Target of RSK2 in Human Skin Cancer.RSK2 成为人类皮肤癌防治的新靶点。
Front Oncol. 2013 Aug 5;3:201. doi: 10.3389/fonc.2013.00201. eCollection 2013.
2
Ribosomal S6 kinase 2 is a key regulator in tumor promoter induced cell transformation.核糖体S6激酶2是肿瘤启动子诱导细胞转化中的关键调节因子。
Cancer Res. 2007 Sep 1;67(17):8104-12. doi: 10.1158/0008-5472.CAN-06-4668.
3
RSK2 and its binding partners in cell proliferation, transformation and cancer development.RSK2及其在细胞增殖、转化和癌症发展中的结合伙伴。
Arch Pharm Res. 2017 Mar;40(3):291-303. doi: 10.1007/s12272-016-0880-z. Epub 2016 Dec 24.
4
RSK2 as a key regulator in human skin cancer.RSK2 作为人类皮肤癌的关键调节因子。
Carcinogenesis. 2012 Dec;33(12):2529-37. doi: 10.1093/carcin/bgs271. Epub 2012 Aug 23.
5
Novel wiring of the AKT-RSK2 signaling pathway plays an essential role in cancer cell proliferation via a G/S cell cycle transition.AKT-RSK2信号通路的新型调控机制通过G/S期细胞周期转换在癌细胞增殖中发挥关键作用。
Biochem Biophys Res Commun. 2023 Jan 29;642:66-74. doi: 10.1016/j.bbrc.2022.12.048. Epub 2022 Dec 19.
6
Eriodictyol inhibits RSK2-ATF1 signaling and suppresses EGF-induced neoplastic cell transformation.圣草次苷抑制 RSK2-ATF1 信号通路并抑制 EGF 诱导的肿瘤细胞转化。
J Biol Chem. 2011 Jan 21;286(3):2057-66. doi: 10.1074/jbc.M110.147306. Epub 2010 Nov 22.
7
Molecular Targeting of ERKs/RSK2 Signaling Axis in Cancer Prevention.癌症预防中ERK/RSK2信号轴的分子靶向作用
J Cancer Prev. 2015 Sep;20(3):165-71. doi: 10.15430/JCP.2015.20.3.165.
8
A regulatory mechanism for RSK2 NH(2)-terminal kinase activity.一种针对RSK2氨基末端激酶活性的调节机制。
Cancer Res. 2009 May 15;69(10):4398-406. doi: 10.1158/0008-5472.CAN-08-4959. Epub 2009 May 12.
9
Targeting RSK2 in Cancer Therapy: A Review of Natural Products.癌症治疗中靶向Rsk2:天然产物综述
Anticancer Agents Med Chem. 2025;25(1):35-41. doi: 10.2174/0118715206329546240830055233.
10
Kaempferol targets RSK2 and MSK1 to suppress UV radiation-induced skin cancer.山奈酚靶向RSK2和MSK1以抑制紫外线辐射诱导的皮肤癌。
Cancer Prev Res (Phila). 2014 Sep;7(9):958-967. doi: 10.1158/1940-6207.CAPR-14-0126. Epub 2014 Jul 3.

引用本文的文献

1
RSK2 and its binding partners: an emerging signaling node in cancers.核糖体S6激酶2(RSK2)及其结合伴侣:癌症中一个新出现的信号节点
Arch Pharm Res. 2025 May;48(5):365-383. doi: 10.1007/s12272-025-01543-3. Epub 2025 May 5.
2
RSK2-mediated cGAS phosphorylation induces cGAS chromatin-incorporation-mediated cell transformation and cancer cell colony growth.RSK2介导的cGAS磷酸化诱导cGAS染色质掺入介导的细胞转化和癌细胞集落生长。
Cell Death Discov. 2024 Oct 18;10(1):442. doi: 10.1038/s41420-024-02208-8.
3
Targeting RSK2 in Cancer Therapy: A Review of Natural Products.

本文引用的文献

1
RSK2 as a key regulator in human skin cancer.RSK2 作为人类皮肤癌的关键调节因子。
Carcinogenesis. 2012 Dec;33(12):2529-37. doi: 10.1093/carcin/bgs271. Epub 2012 Aug 23.
2
Insights into the inhibition of the p90 ribosomal S6 kinase (RSK) by the flavonol glycoside SL0101 from the 1.5 Å crystal structure of the N-terminal domain of RSK2 with bound inhibitor.从 RSK2 氨基端结构域与结合抑制剂的 1.5 Å 晶体结构深入了解黄酮醇糖苷 SL0101 对 p90 核糖体 S6 激酶 (RSK) 的抑制作用。
Biochemistry. 2012 Aug 21;51(33):6499-510. doi: 10.1021/bi300620c. Epub 2012 Aug 6.
3
Phosphorylation of histone H2B serine 32 is linked to cell transformation.
癌症治疗中靶向Rsk2:天然产物综述
Anticancer Agents Med Chem. 2025;25(1):35-41. doi: 10.2174/0118715206329546240830055233.
4
Designing a novel drug-drug conjugate as a prodrug for breast cancer therapy: in silico insights.设计一种新型药物-药物偶联物作为乳腺癌治疗的前药:计算机模拟见解
Mol Divers. 2025 Apr;29(2):991-1007. doi: 10.1007/s11030-024-10886-w. Epub 2024 Jun 4.
5
Ribosomal S6 kinase 2-forkhead box protein O4 signaling pathway plays an essential role in melanogenesis.核糖体S6激酶2-叉头框蛋白O4信号通路在黑色素生成中起重要作用。
Sci Rep. 2024 Apr 24;14(1):9440. doi: 10.1038/s41598-024-60165-9.
6
Dysregulated CREB3 cleavage at the nuclear membrane induces karyoptosis-mediated cell death.核膜上 CREB3 的切割失调会诱导核质分裂介导的细胞死亡。
Exp Mol Med. 2024 Mar;56(3):686-699. doi: 10.1038/s12276-024-01195-1. Epub 2024 Mar 13.
7
A novel ribosomal protein S6 kinase 2 inhibitor attenuates the malignant phenotype of cutaneous malignant melanoma cells by inducing cell cycle arrest and apoptosis.一种新型核糖体蛋白 S6 激酶 2 抑制剂通过诱导细胞周期停滞和细胞凋亡来减弱皮肤恶性黑色素瘤细胞的恶性表型。
Bioengineered. 2022 May;13(5):13555-13570. doi: 10.1080/21655979.2022.2080364.
8
Gene Profiling of a 3D Psoriatic Skin Model Enriched in T Cells: Downregulation of Promotes Keratinocyte Proliferation through Excessive ERK1/2 Signaling.富含 T 细胞的 3D 银屑病皮肤模型的基因谱分析:下调 通过过度 ERK1/2 信号促进角质形成细胞增殖。
Cells. 2022 Sep 16;11(18):2904. doi: 10.3390/cells11182904.
9
Functional Phosphoproteomics in Cancer Chemoresistance Using CRISPR-Mediated Base Editors.基于 CRISPR 介导的碱基编辑器的癌症化疗耐药性中的功能磷酸化蛋白质组学。
Adv Sci (Weinh). 2022 Oct;9(30):e2200717. doi: 10.1002/advs.202200717. Epub 2022 Aug 31.
10
Association Between and Clinical Indexes of Primary Breast Cancer: A Meta-Analysis Based on mRNA Microarray Data.原发性乳腺癌与临床指标之间的关联:基于mRNA微阵列数据的荟萃分析。
Front Genet. 2021 Nov 1;12:770134. doi: 10.3389/fgene.2021.770134. eCollection 2021.
组蛋白 H2B 丝氨酸 32 的磷酸化与细胞转化有关。
J Biol Chem. 2011 Jul 29;286(30):26628-37. doi: 10.1074/jbc.M110.215590. Epub 2011 Jun 6.
4
Phosphorylation of H2AX at Ser139 and a new phosphorylation site Ser16 by RSK2 decreases H2AX ubiquitination and inhibits cell transformation.RSK2 对 H2AX 丝氨酸 139 及新磷酸化位点丝氨酸 16 的磷酸化作用降低了 H2AX 的泛素化,并抑制了细胞转化。
Cancer Res. 2011 Jan 15;71(2):393-403. doi: 10.1158/0008-5472.CAN-10-2012. Epub 2011 Jan 11.
5
Phosphorylation of caspase-8 (Thr-263) by ribosomal S6 kinase 2 (RSK2) mediates caspase-8 ubiquitination and stability.核糖体 S6 激酶 2 (RSK2) 对 caspase-8 (Thr-263) 的磷酸化介导了 caspase-8 的泛素化和稳定性。
J Biol Chem. 2011 Mar 4;286(9):6946-54. doi: 10.1074/jbc.M110.172338. Epub 2010 Dec 23.
6
Eriodictyol inhibits RSK2-ATF1 signaling and suppresses EGF-induced neoplastic cell transformation.圣草次苷抑制 RSK2-ATF1 信号通路并抑制 EGF 诱导的肿瘤细胞转化。
J Biol Chem. 2011 Jan 21;286(3):2057-66. doi: 10.1074/jbc.M110.147306. Epub 2010 Nov 22.
7
RSK2 mediates NF-{kappa}B activity through the phosphorylation of IkappaBalpha in the TNF-R1 pathway.RSK2 通过 TNF-R1 通路中 IkappaBalpha 的磷酸化来介导 NF-κB 活性。
FASEB J. 2010 Sep;24(9):3490-9. doi: 10.1096/fj.09-151290. Epub 2010 Apr 12.
8
Structural diversity of the active N-terminal kinase domain of p90 ribosomal S6 kinase 2.p90 核糖体 S6 激酶 2 的活性 N 端激酶结构域的结构多样性。
PLoS One. 2009 Nov 30;4(11):e8044. doi: 10.1371/journal.pone.0008044.
9
Interaction between phenolics and gut microbiota: role in human health.酚类物质与肠道微生物群之间的相互作用:对人类健康的作用。
J Agric Food Chem. 2009 Aug 12;57(15):6485-501. doi: 10.1021/jf902107d.
10
A regulatory mechanism for RSK2 NH(2)-terminal kinase activity.一种针对RSK2氨基末端激酶活性的调节机制。
Cancer Res. 2009 May 15;69(10):4398-406. doi: 10.1158/0008-5472.CAN-08-4959. Epub 2009 May 12.